DGX.NYSEQuest Diagnostics INC

Form 4: Quest Diagnostics Executive Increases Stake via DRIP

Sentiment:

Statement of Changes in Beneficial Ownership

📋All filings for Quest Diagnostics INC
🔒Login to Follow

Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, acquired 37 shares through a dividend reinvestment plan.

Summary

  • Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, acquired 37 shares of common stock.
  • The transaction occurred on April 20, 2026, at a price of $194.696 per share.
  • The acquisition was executed through a dividend reinvestment plan.
  • Following this transaction, the reporting person holds a total of 11,901 shares of Quest Diagnostics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding insider share accumulation.

Positives

  • Insider demonstrates commitment to the company by increasing equity holdings through dividend reinvestment.

Negatives

  • None identified.

Risks

  • None identified.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider acquisitions via dividend reinvestment plans are standard corporate governance practices and generally reflect long-term alignment between executives and shareholders.

Comparison to Industry Standards

  • The transaction is consistent with standard executive compensation and equity ownership practices among large-cap healthcare companies.

Stakeholder Impact

  • Minimal impact on shareholders; reflects standard executive equity management.

Key Dates

DateDescription
04/20/2026Date of the transaction involving the acquisition of 37 shares.
04/24/2026Date the Form 4 was signed and filed.

Keywords

Quest Diagnostics, DGX, Insider Trading, Form 4, Dividend Reinvestment, Mark E. Delaney

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.